(Q44239280)

1 December 2017

title

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT. (English)

1 reference

1 December 2017

M Viganò

1

1 reference

1 December 2017

C Vener

2

1 reference

1 December 2017

P Lampertico

3

1 reference

1 December 2017

C Annaloro

4

1 reference

1 December 2017

C Pichoud

5

1 reference

1 December 2017

F Zoulim

6

1 reference

1 December 2017

F Facchetti

7

1 reference

1 December 2017

F Poli

8

1 reference

1 December 2017

M Scalamogna

9

1 reference

1 December 2017

G Lambertenghi Deliliers

10

1 reference

1 December 2017

M Colombo

11

1 reference

1 December 2017

language of work or name

English

0 references

publication date

12 April 2010

1 reference

Bone Marrow Transplantation

1 December 2017

published in

1 reference

1 December 2017

volume

46

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

125-131

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2010.70

1 December 2017

exact match

0 references

cites work

Hepatitis B virus infection and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Prophylaxis and treatment of hepatitis B in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

7 January 2021

Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

7 January 2021

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

7 January 2021

HBeAg-negative hepatitis B in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

7 January 2021

Clinical and biochemical reactivation of HBV infection in a thalassemic patient after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.70

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.70

1 reference

Dimensions Publication ID

1 December 2017

1007689036

0 references

Fatcat ID

release_jcl6w45c2bd5xaf6cfpnmagoai

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jcl6w45c2bd5xaf6cfpnmagoai

24 November 2022

mapped directly with Wikidata item

1 reference